Syneron's elure™ Wins Allure Magazine's BEST OF BEAUTY Award For The Second Consecutive Year

YOKNEAM, Israel, Sept. 18, 2012 /PRNewswire/ -- Syneron Medical (NASDAQ: ELOS), www.syneron.com, the global leader in medical aesthetic products and technology, announced today that Allure Magazine has named elure™ Lotion its "Best Anti-Ager for Discoloration" in its annual Best of Beauty issue, which is published in October every year.  This is the second consecutive win for elure in Allure Magazine's Best of Beauty issue; elure™ Lotion and the elure™ Night Cream won the coveted award in the Big Breakthroughs category in October 2011.

(Logo: http://photos.prnewswire.com/prnh/20120528/535447)

Allure Magazine selects their winners based on real, noticeable results. Among the thousands of beauty products launched every year, "these are the products that truly deliver," the magazine says, noting that elure Lotion is one of the only products readers need to know and own.

Louis Scafuri, Chief Executive Officer of Syneron, commented, "Due to its outstanding efficacy and safety profile, elure has rapidly become a leading home use solution recommended by physicians around the world for correcting skin discoloration.  We are thrilled and honored to receive this award from the leading beauty experts at Allure Magazine."

In addition to the Best of Beauty award, Allure Magazine also named elure Lotion one of "50 Beauty Products to Buy Before You Die".  Hailed as a "powerful skin-brightening cream," by Allure, dermatologist Leslie Baumann, M.D., a member of Syneron's Medical Advisory Board said, "my patients are seeing their hyperpigmentation fade within four weeks."

"elure is safe, simple-to-use and works well on all skin types," states Anne Chapas, M.D., dermatologist and Medical Director for Union Square Laser Dermatology in Manhattan, New York.  "Patients rightfully are enthusiastic when they experience quick results without irritation.  Within a month of regular use, skin appears brighter and more even toned."

See elure Lotion's Best of Beauty award for "Best Anti-Ager for Discoloration" in Allure Magazine's October 2012 issue. 

See elure Lotion highlighted as one of Allure Magazine's "50 Beauty Products to Buy Before You Die" here: http://www.allure.com/beauty-products/2012/beauty-products-to-buy-before-you-die#slide=44

For more information about elure's full range of products visit www.elureskin.com or follow us on Facebook: http://www.facebook.com/elureskin.

About Syneron Medical Ltd.

Syneron Medical Ltd. – a company devoted to real technology, real science and real results – is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. With its innovative approach to aesthetic treatments, Syneron has now entered into one of the largest in-demand applications, skin lightening. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

elure™ is sold as a topical cosmetic intended to beautify your skin and cosmetics are not subject to evaluation by the FDA. All product information provided is intended to be for informational purposes only. The information about skin conditions provided herein does not constitute medical or pharmaceutical advice and should not be relied upon as a substitute for qualified medical consultation with health professionals.

Additional information can be found at www.syneron.com

SOURCE Syneron Medical Ltd.